Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Healios KK Ord Shs HLOSF

HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. The products are ophthalmological surgery adjuvants, mainly contain brilliant blue G-250 (BBG250) which help capsule temporarily safely stained to protect the inner limiting membranes and lens during surgery of vitreous and cataract. The iPSC regenerative medicine product line contains HLCR011 and HLCR012. The products are in the preclinical testing and preparation for trial in Japan, which are candidate of regenerative medicine products. The products are iPS cell derived retinal pigment epithelium (RPE) cell suspension and sheet developed in Japan, United States and Europe.


PINL:HLOSF - Post by User

Post by The300on Dec 14, 2010 2:13pm
530 Views
Post# 17844722

Takeout Candidate

Takeout CandidateWith the consolidation that is going on in the mining space, Halo would be a prime takeover candidate.  The most obvious suitor in this situation would be Hudbay.

Hudbay has gone on record stating that they want to ramp up zinc production.  We also know that their current feed  stockpile is dwindling, and other potential feed is still a few years from coming online. (eg. VMS Ventures)

The most logical and cost effective way to make their plans come to fruition would be to use Halo's Sherridon property for easily accessible feed (open pit).

I would have to imagine that a takeover offer is a real possibility.  If not, at the very least I would have to imagine that Hudbay has had this conversation with Halo management already.  As it stands now, Hudbay has the option, if fully exercised, to own 67.5% of the 1.1 sq. km joint venture, which leaves approx. 199 sq. km open to negotiation.

Hudbay has already incurred the hard costs of building the plants in the area (approx. 60km from Sherridon), so why re-invent the wheel when the feed is nearby a la Halo.

The stock continues to be very thin on the ask as most current shareholders are well aware of the potential here, especially with Hudbay now in the forefront.  It won't take much to move this stock at this point.  $20,000 worth of buying pretty much takes us up to $.70 (barring any new sell orders).

I have been watching level II and I still get the distinct feeling that the ask right now are artificial (put there by someone/organization) to 1. keep an orderly market 2. keep the stock from gapping up.

Why do I think this?  The level II is almost too orderly.  Earlier today there were very small amounts on the ask, with 1 seller at each position.  Then a little while later, same asks, but with 2 sellers at each position, and all with relatively small positions.

Once the private placement closes we will have a better idea of where we are headed.

Holding long and with confidence.

As always, the above is my humble opinion.

The 300 (Molon Lave)

<< Previous
Bullboard Posts
Next >>